Plasma exchange could expand treatment options for rare disease that threatens vision

Plasma exchange can help treat people with a rare inflammatory disease that can cause blindness, according to a systematic ...

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

One trial, SIGMA, will evaluate Grifols’ intravenous immunoglobulin (Ig) GAMUNEX ® -C (immune globulin injection [human], 10% caprylate ...